VERA Vera Therapeutics, Inc.

Fundamentals / CIK 0001831828 / USD

Vera Therapeutics, Inc. reported $465.8M in total assets and a net loss of $415.3M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VERA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$280.1MFY 2020 Net Income: -$53.41M2020FY 2021 Net Income: -$32.61M2021FY 2022 Net Income: -$89.06M2022FY 2023 Net Income: -$95.99M2023FY 2024 Net Income: -$152.1M2024FY 2025 Net Income: -$299.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $215.3M $126.2M $78.22M $68.99M $22.48M $45.21M
Total Operating Expenses $315.5M $167.2M $102.0M $90.90M $34.40M $52.24M
Operating Income -$315.5M -$167.2M -$102.0M -$90.90M -$34.40M -$52.24M
EBITDA -$315.0M -$167.1M -$102.0M -$91.75M -$34.23M -$51.99M
Interest Income $24.48M $20.71M $7.98M $1.75M $15K $8.0K
Interest Expense $7.53M $7.63M $3.79M $992K $20K $166K
Income Before Tax -$299.6M -$152.1M -$95.99M -$89.06M -$32.61M -$53.41M
Income Tax Expense $1.0K $1.0K $1.0K $1.0K $1.0K -$1.0K
Net Income -$299.6M -$152.1M -$95.99M -$89.06M -$32.61M -$53.41M
Basic EPS -$4.66 -$2.75 -$2.25 -$3.35 -$2.43 -$166.93
Diluted EPS -$4.66 -$2.75 -$2.25 -$3.35 -$2.43 -$166.93
Basic Shares Outstanding 64.2M 55.3M 42.7M 26.6M 13.4M 320.0K
Diluted Shares Outstanding 64.2M 55.3M 42.7M 26.6M 13.4M 320.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $10.28M -- -- -- $0 -- -- --
Cost of Revenue $3.30M -- -- -- $0 -- -- --
Gross Profit $6.98M -- -- -- $0 -- -- --
Research & Development $41.25M $60.08M $86.01M $59.31M $56.47M $58.20M $41.28M $33.35M
Selling, General & Admin $61.43M -- -- -- $27.46M -- -- --
Total Operating Expenses -- $112.5M $125.1M $94.21M $83.93M $80.14M $57.19M $48.91M
Operating Income -$95.70M -$112.5M -$125.1M -$94.21M -$83.93M -$80.14M -$57.19M -$48.91M
EBITDA -$94.88M -$112.4M -$125.0M -$94.07M -$83.80M -$80.02M -$57.11M -$48.86M
Interest Income $4.34M $5.35M $6.36M $5.52M $5.74M $6.32M $6.91M $6.66M
Interest Expense $1.87M $1.85M $1.82M $1.90M $1.96M $1.87M $1.79M $1.87M
Net Income -$93.71M -$109.5M -$121.0M -$91.10M -$80.29M -$76.53M -$51.69M -$43.42M
Basic EPS -$1.30 -$1.52 -$1.69 -- -$1.26 -$1.20 -$0.81 --
Diluted EPS -$1.30 -$1.52 -$1.69 -- -$1.26 -$1.20 -$0.81 --
Basic Shares Outstanding 72.1M 71.8M 71.5M -- 63.8M 63.8M 63.7M --
Diluted Shares Outstanding 72.1M 71.8M 71.5M -- 63.8M 63.8M 63.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $354.7M $92.65M $45.68M $43.46M $79.67M $53.65M
Short-Term Investments $359.9M $548.2M $115.0M $71.19M $0 --
Cash & Short-Term Investments $714.6M $640.9M $160.7M $114.7M $79.67M $53.65M
Accounts Receivable, Net $0 -- -- -- -- --
Inventory $0 -- -- -- -- --
Other Current Assets $4.27M $1.38M $2.24M $719K $480K $392K
Total Current Assets $728.9M $651.2M $172.0M $125.7M $82.54M $54.26M
Property, Plant & Equipment, Net $1.37M $960K $92K $51K $0 --
Intangible Assets $0 -- -- -- -- --
Long-Term Investments -- -- $11K $58K $867K $0
Other Non-Current Assets $5.85M -- -- -- -- --
Total Non-Current Assets $5.85M $4.46M $3.52M $5.74M $1.21M $293K
Total Assets $734.7M $655.7M $175.5M $131.4M $83.75M $54.55M
Accounts Payable $21.90M $7.67M $11.12M $11.99M $1.39M $909K
Other Current Liabilities $3.0K $217K -- -- -- --
Total Current Liabilities $53.45M $25.37M $22.30M $25.60M $7.69M $2.41M
Long-Term Debt $74.84M $50.69M $49.88M $24.81M $4.92M $0
Other Non-Current Liabilities $1.92M -- -- -- -- --
Total Non-Current Liabilities $76.76M $53.16M $51.56M $28.93M $6.47M $1.92M
Total Liabilities $130.2M $78.53M $73.86M $54.53M $14.16M $4.33M
Total Debt (incl. Leases) $77.31M $54.64M $53.71M $31.29M $13.92M $0
Common Stock $71K $64K $44K $28K -- --
Retained Earnings -$760.9M -$461.2M -$309.1M -$213.1M -$124.1M -$91.45M
Accumulated Other Comp. Income $786K $393K $251K -$224K $0 --
Total Stockholders' Equity $604.5M $577.2M $101.7M $76.91M $69.59M -$89.35M
Total Equity $604.5M $577.2M $101.7M $76.91M $69.59M -$89.35M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $55.32M $48.88M $114.4M $354.7M $57.77M $49.12M $55.09M $92.65M
Short-Term Investments $328.7M $450.3M $482.4M $359.9M $439.6M $507.7M $534.7M $548.2M
Cash & Short-Term Investments $384.0M $499.2M $596.8M $714.6M $497.4M $556.8M $589.8M $640.9M
Accounts Receivable, Net $11.98M -- -- $0 -- -- -- --
Inventory $7.08M -- -- $0 -- -- -- --
Other Current Assets $6.91M $4.21M $2.50M $4.27M $1.15M $1.62M $1.79M $1.38M
Total Current Assets $441.3M $527.5M $615.8M $728.9M $511.3M $571.4M $606.1M $651.2M
Property, Plant & Equipment, Net -- $813K $945K $1.37M $1.16M $1.15M $1.06M $960K
Intangible Assets $20.50M -- -- $0 -- -- -- --
Other Non-Current Assets $3.97M $5.49M $5.94M $5.85M -- -- -- --
Total Non-Current Assets $24.47M $5.49M $5.94M $5.85M $6.19M $7.17M $4.09M $4.46M
Total Assets $465.8M $533.0M $621.7M $734.7M $517.5M $578.5M $610.2M $655.7M
Accounts Payable $20.17M $14.57M $13.91M $21.90M $17.95M $13.16M $9.26M $7.67M
Other Current Liabilities -- -- -- $3.0K -- -- -- $217K
Total Current Liabilities $55.77M $48.32M $45.15M $53.45M $41.88M $33.55M $21.89M $25.37M
Long-Term Debt $75.43M $75.23M $75.03M $74.84M $74.65M $74.46M $50.91M $50.69M
Other Non-Current Liabilities $1.36M $1.68M $1.86M $1.92M -- -- -- --
Total Non-Current Liabilities $76.79M $76.91M $76.89M $76.76M $76.74M $76.70M $53.27M $53.16M
Total Liabilities $132.6M $125.2M $122.0M $130.2M $118.6M $110.3M $75.17M $78.53M
Total Debt (incl. Leases) $75.43M $75.23M $75.03M $77.31M $77.22M $77.55M $54.47M $54.64M
Common Stock $72K $72K $72K $71K $64K $64K $64K $64K
Retained Earnings -$1.09B -$991.4M -$881.9M -$760.9M -$669.8M -$589.5M -$512.9M -$461.2M
Accumulated Other Comp. Income -$704K -$403K -$156K $786K $881K $527K $654K $393K
Total Stockholders' Equity $333.2M $407.8M $499.7M $604.5M $398.9M $468.3M $535.0M $577.2M
Total Equity $333.2M $407.8M $499.7M $604.5M $398.9M $468.3M $535.0M $577.2M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$299.6M -$152.1M -$95.99M -$89.06M -$32.61M -$53.41M
Depreciation & Amortization $468K $105K $21K -$846K $176K $251K
Stock-Based Compensation $37.93M $20.80M $11.49M $8.89M $3.01M $331K
Change in Payables $13.91M -$3.45M -$873K $10.61M $475K $567K
Operating Cash Flow -$241.1M -$134.7M -$92.18M -$67.60M -$23.71M -$34.81M
Capital Expenditure -$630K -$972K -$63K -$62K $0 -$99K
Free Cash Flow -$241.7M -$135.7M -$92.24M -$67.66M -$23.71M -$34.91M
Purchases of Investments -$310.4M -$703.0M -$224.9M -$148.5M $0 --
Investing Cash Flow $194.3M -$425.0M -$39.43M -$70.55M -$4.20M -$42K
Common Stock Issued -- -- -- $2.00M $0 --
Share Repurchases $0 -$13K $0 -- -- --
Financing Cash Flow $308.9M $606.7M $133.5M $101.9M $53.88M $85.29M
Net Change in Cash $262.1M $46.97M $1.93M -$36.22M $25.97M $50.44M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$93.71M -$109.5M -$121.0M -$91.10M -$80.29M -$76.53M -$51.69M -$43.42M
Depreciation & Amortization $823K $132K $140K $135K $129K $119K $85K $55K
Stock-Based Compensation $15.73M $15.86M $13.21M $10.96M $9.74M $9.47M $7.74M $6.22M
Change in Payables $5.60M $664K -$7.97M $3.62M $4.79M $3.90M $1.60M $3.06M
Operating Cash Flow -$99.18M -$100.3M -$106.5M -$69.99M -$61.91M -$54.80M -$54.41M -$39.18M
Capital Expenditure $0 $0 -$23K -$102K -$133K -$208K -$187K -$645K
Free Cash Flow -$99.18M -$100.3M -$106.5M -$70.10M -$62.04M -$55.01M -$54.59M -$39.83M
Purchases of Investments -$48.51M -$98.06M -$210.6M -$24.50M -$98.70M -$97.26M -$89.99M -$294.0M
Investing Cash Flow $101.9M $32.86M -$137.8M $80.66M $69.76M $28.54M $15.32M -$221.4M
Financing Cash Flow $3.71M $1.92M $3.94M $286.3M $797K $20.29M $1.53M $326.0M
Net Change in Cash $6.45M -$65.47M -$240.4M $297.0M $8.65M -$5.97M -$37.56M $65.39M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -49.6% -26.4% -94.4% -115.8% -46.9% --
Return on Assets (ROA) -40.8% -23.2% -54.7% -67.8% -38.9% -97.9%
Current Ratio 13.64x 25.67x 7.71x 4.91x 10.73x 22.55x
Quick Ratio 13.64x 25.26x 7.21x 4.48x 10.36x 22.30x
Debt to Equity 0.13x 0.09x 0.53x 0.41x 0.20x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -124.6% -98.6% -73.8% -49.6% -63.2% -46.6% -32.8% -26.4%
Return on Assets (ROA) -89.2% -75.4% -59.3% -40.8% -48.7% -37.7% -28.8% -23.2%
Current Ratio 7.91x 10.92x 13.64x 13.64x 12.21x 17.03x 27.68x 25.67x
Quick Ratio 7.78x 10.33x 13.22x 13.64x 11.88x 16.59x 26.94x 25.26x
Debt to Equity 0.23x 0.18x 0.15x 0.13x 0.19x 0.17x 0.10x 0.09x
Source: SEC EDGAR CompanyFacts (CIK 0001831828) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal